臨床検査67巻12号

2023年12月発行

今月の特集 中枢神経系感染症アップデート 医療関連・免疫不全患者における中枢神経系感染症

造血幹細胞移植患者における中枢神経系感染症

著者： 冲中敬二¹

所属機関： ¹国立がん研究センター東病院感染症科

ページ範囲：P.1351 - P.1357

Point

●中枢神経系合併症を疑った場合は非感染性を含め原因の精査を行う．

●中枢神経系合併症の鑑別を検討する際に，移植後の時期は非常に重要な情報となる．

●感染性合併症の原因病原体としてはヒトヘルペスウイルス6（HHV-6）をはじめとしたウイルスが比較的多い．

●HHV-6脳炎は，生着前後までに軽微な精神・神経症状が出た場合に最初に疑い，経験的治療導入を検討する．

参考文献

1）Wieczorek M, Mariotto S, Ferrari S, et al：Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series. Bone Marrow Transplant　57：1133-1141，2022

2）Server A, Bargalló N, Fløisand Y, et al：Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation. Neuroradiology　59：105-126，2017

3）Maschke M, Dietrich U, Prumbaum M, et al：Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant　23：1167-1176，1999

4）Balaguer Rosello A, Bataller L, Lorenzo I, et al：Infections of the Central Nervous System after Unrelated Donor Umbilical Cord Blood Transplantation or Human Leukocyte Antigen-Matched Sibling Transplantation. Biol Blood Marrow Transplant　23：134-139，2017

5）Hanajiri R, Kobayashi T, Yoshioka K, et al：Central nervous system infection following allogeneic hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther　10：22-28，2017

6）日本造血細胞移植学会：造血細胞移植ガイドライン—ウイルス感染症の予防と治療　EBウイルス関連リンパ増殖症，2018（https://www.jstct.or.jp/uploads/files/guideline/01_03_02_ebv.pdf）（最終アクセス：2023年9月8日）

7）Averbuch D, Engelhard D：Central Nervous System (CNS) Infections After Hematopoietic Stem Cell or Solid Organ Transplantation. In: Transplant Infections, 4th ed (Ljungman P, Snydman DR, Boeckh M, eds), Springer Cham, Switzerland, pp283-310, 2016

8）Schmidt-Hieber M, Schwender J, Heinz WJ, et al：Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents. Haematologica　96：142-149，2011

9）Schmidt-Hieber M, Silling G, Schalk E, et al：CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol　27：1207-1225，2016

10）Zerr DM, Corey L, Kim HW, et al：Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis　40：932-940，2005

11）Hentrich M, Oruzio D, Jäger G, et al：Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol　128：66-72，2005

12）Ogata M, Satou T, Kadota J, et al：Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis　57：671-681，2013

13）Ogata M, Kikuchi H, Satou T, et al：Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis　193：68-79，2006

14）Scheurer ME, Pritchett JC, Amirian ES, et al：HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis. Bone Marrow Transplant　48：574-580，2013

15）Ogata M, Oshima K, Ikebe T, et al：Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant　52：1563-1570，2017

16）日本造血・免疫細胞療法学会：造血細胞移植ガイドライン　HHV-6（第2版），2022（https://www.jstct.or.jp/uploads/files/guideline/01_03_03_hhv6_02.pdf）（最終アクセス：2023年9月8日）

17）Seeley WW, Marty FM, Holmes TM, et al：Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology　69：156-165，2007

18）Dockrell DH, Paya CV：Human herpesvirus-6 and -7 in transplantation. Rev Med Virol　11：23-36，2001

19）Betts BC, Young JA, Ustun C, et al：Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?. Biol Blood Marrow Transplant　17：1562-1568，2011

20）Hill JA, Myerson D, Sedlak RH, et al：Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature. Transpl Infect Dis　16：477-483，2014

21）Hill JA, Koo S, Guzman Suarez BB, et al：Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant　18：1638-1648，2012

22）Steinbach WJ, Marr KA, Anaissie EJ, et al：Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect　65：453-464，2012

23）Dadwal SS, Hohl TM, Fisher CE, et al：American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients. Transplant Cell Ther　27：201-211，2021

24）Ruchlemer R, Ben-Ami R, Bar-Meir M, et al：Ibrutinib-associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: An observational study. Mycoses　62：1140-1147，2019

25）Ghez D, Calleja A, Protin C, et al：Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib. Blood　131：1955-1959，2018

26）Kourkoumpetis TK, Desalermos A, Muhammed M, et al：Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature. Medicine (Baltimore)　91：328-336，2012

27）Donnelly JP, Chen SC, Kauffman CA, et al：Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis　71：1367-1376，2020

28）Jenks JD, Mehta SR, Hoenigl M：Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?. Med Mycol　57(Supplement_2)：S168-S178，2019

29）Schwartz S, Reisman A, Troke PF：The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection　39：201-210，2011

30）Lanternier F, Sun HY, Ribaud P, et al：Mucormycosis in Organ and Stem Cell Transplant Recipients. Clin Infect Dis　54：1629-1636，2012

31）Almyroudis NG, Sutton DA, Linden P, et al：Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant　6：2365-2374，2006

32）Cornely OA, Alastruey-Izquierdo A, Arenz D, et al：Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis　19：e405-e421，2019

33）Lionakis MS, Lewis RE, Kontoyiannis DP：Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions. Clin Infect Dis　67：1621-1630，2018

34）Axell-House DB, Wurster S, Jiang Y, et al：Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. J Fungi (Basel)　7：217，2021

35）Sumi M, Aosai F, Norose K, et al：Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients. Int J Hematol　98：214-222，2013

36）日本造血細胞移植学会：造血細胞移植ガイドライン　造血細胞移植後の感染管理（第4版），2017（https://www.jstct.or.jp/uploads/files/guideline/01_01_kansenkanri_ver04.pdf）（最終アクセス：2023年9月11日）

37）Tomblyn M, Chiller T, Einsele H, et al：Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant　15：1143-1238，2009

38）Gajurel K, Dhakal R, Montoya JG：Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations. Curr Opin Infect Dis　28：283-292，2015

39）Robert-Gangneux F, Meroni V, Dupont D, et al：Toxoplasmosis in Transplant Recipients, Europe, 2010-2014. Emerg Infect Dis　24：1497-1504，2018